Artiva Biotherapeutics ARTV
NASDAQ ARTV
$4.07 +0.01 (+0.25%)
At close: Nov 11, 2026 · 4:00 PM EST

Artiva Biotherapeutics (ARTV) Other Non-Current Liabilities (2023 - 2024)

Updated

Artiva Biotherapeutics (ARTV) reported Other Liabilities of $73,000 for Q4 2024, down 99.7% from $25.17 million a year earlier and unchanged from the prior quarter.

Analysis

Artiva Biotherapeutics (ARTV) Other Non-Current Liabilities (2023 - 2024) Analysis & Trends

Dating back to Q4 2023, Artiva Biotherapeutics' Other Liabilities record includes 4 quarters.

  • By year, Other Liabilities came in at $25.17 million in FY2023.
  • Five-year quarterly Other Liabilities spans a low of $73,000 in Q3 2024 and a high of $27.79 million in Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Artiva Biotherapeutics 200.70 Mn -118.40 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 73,000.00
Sep 30, 2024 73,000.00
Jun 30, 2024 27.79 Mn
Dec 31, 2023 25.17 Mn
API Access

Artiva Biotherapeutics Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ARTV&period=max&api_key=YOUR_API_KEY